Cargando...
Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1
Prostate cancer (PCa) is one of the most common malignancies worldwide, and with a limited number of treatments for this type of cancer, its incidence is rapidly increasing. Patients presenting with PCa are likely to experience disease recurrence, which represents a considerable clinical challenge....
Gardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
D.A. Spandidos
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6341651/ https://ncbi.nlm.nih.gov/pubmed/30675291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.9822 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|